BSX FY 2025 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

FY 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$20.1B+19.9% YoY

Gross Profit

$13.9B69.0% margin

Operating Income

$4.0B19.8% margin

Net Income

$2.9B14.4% margin

EPS (Diluted)

$1.94

Cash Flow

Operating Cash Flow

$4.5B

Free Cash Flow

$3.7B

Stock-Based Comp.

$299M

Balance Sheet

Total Assets

$43.7B

Total Liabilities

$19.2B

Stockholders' Equity

$24.2B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20.1B	$16.7B	+19.9%
Gross Profit	$13.9B	$10.3B	+34.9%
Operating Income	$4.0B	$2.6B	+50.7%
Net Income	$2.9B	$1.9B	+55.7%